Andrew David Petronanos joins swiss Arclif Ventures as Board Senior Advisor
Andrew David Petronanos is the Chief Executive Officer of Dascoli Pharma AG.
He previously worked at Alpha Three Invest as an Investor Relations and founded the consulting and investment advisory firm FINELEAF.
Andrew attended attended CISI, Chartered Institute for Securities & Investment and completed his degree in Marine engineering from Carnegie Polytechnic in Scotland.
Andrew David Petronanos supports the Arclif Group activities on a global scale and is responsible for strategic advice in special projects.